The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: May 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

8. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells

  • 1. Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
  • 2. Spatial epitope barcoding reveals clonal tumor patch behaviors
  • 3. Non-viral precision T cell receptor replacement for personalized cell therapy
  • 4. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
  • 5. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
  • 6. Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion
  • 7. The NALCN channel regulates metastasis and nonmalignant cell dissemination
  • 8. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
  • 9. Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer
  • 10. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Previous
Next

Zhang, W. et al. Cancer Discov. 13 (2): 474–495 (2023).
doi: 10.1158/2159-8290.CD-22-0220.

Summary and graphical abstract by Dr. Alexandra Boitor, EACR Scientific Officer

Summary of the findings

A key experiment in this study made use of spontaneous metastasis mouse models where lung carcinoma cells were subcutaneously transplanted into mice. Once tumours reached 1 cm in diameter, tumours were resected, and the right femur bones were fractured by drilling or bending. Changes in tumour spread and distribution were noticed and proved to be dependent on NG2+ cells. This sparked interest in investigating the relationship between cell differentiation, proliferation and invasion in both homeostatic and pathogenic conditions. Vector images used for the development of this figure were taken from https://www.pngwing.com.

Various cancer types, including breast, lung, prostate, and colon cancers often metastasize to the bone and metastasis reoccurrence can be observed even years after tumour removal. The bone tissue and microenvironment are highly dynamic under both homeostatic and pathogenic conditions. In their study, Zhang et al. investigated the relationship between metastasis initiation and bone remodelling by making use of several pre-clinical cancer models including co-culture studies, 3D cell culture and mouse models for spontaneous bone metastasis. Results from their study identified NG2+ cells as modulators of osteogenesis and bone remodelling in homeostatic and fractured (but otherwise healthy) bone and facilitators of metastasis initiation and development in pathogenic conditions. Zhang et al propose that NG2+ cells and disseminated tumour cells directly interact in a unique way through heterotypic adherens junctions and this interaction promotes the proliferation and motility of cancer cells. At the core of this interaction, and therefore responsible for the pro-metastatic abilities gained by cancer cells was proposed to be N-cadherin expressed on NG2+ cells.  

Future impact

This study proposes a potential connection between bone remodelling and bone metastasis and may explain some circumstantial epidemiologic observations such as increased risk of metastasis in breast cancer survivors following bone fractures or metastatic spreading to the oral cavity and the jaws following dental implants in some patients diagnosed with breast or lung cancer.

Read more in Cancer Discovery

8. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells

  • 1. Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
  • 2. Spatial epitope barcoding reveals clonal tumor patch behaviors
  • 3. Non-viral precision T cell receptor replacement for personalized cell therapy
  • 4. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
  • 5. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
  • 6. Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion
  • 7. The NALCN channel regulates metastasis and nonmalignant cell dissemination
  • 8. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
  • 9. Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer
  • 10. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: December 2025

December 8, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Colin Ratcliffe two years into his EACR-AstraZeneca Postdoctoral Fellowship
News

Colin Ratcliffe’s experience of an EACR-AstraZeneca Postdoctoral Fellowship

February 6, 2026
Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship
News

Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship

February 2, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR